Cystic Fibrosis (CF) management for children requires a dedicated, daily routine to maintain lung health and prevent infections. For many Australian parents, the Aerobika Oscillating Positive Expiratory Pressure (OPEP) device has become a staple in this routine. However, the most common question remains: Is the Aerobika safe for kids?
As a parent or caregiver, your primary concern is ensuring that any medical device introduced to your child’s therapy is both effective and non-toxic. The Aerobika is specifically engineered to meet these needs, combining high-efficiency airway clearance with a medical-grade construction that is both BPA-free and latex-free.
This article explores the safety profile, clinical benefits, and practical use of the Aerobika OPEP device within a pediatric cystic fibrosis management plan.
What is the Aerobika OPEP Device?
The Aerobika is a handheld, drug-free medical device designed to assist with airway clearance. It utilizes Oscillating Positive Expiratory Pressure (OPEP) to help patients with chronic respiratory conditions, such as cystic fibrosis and bronchiectasis, move stubborn mucus from the smaller airways to the larger airways, where it can be coughed out.
How OPEP Technology Works for Children
When a child exhales through the Aerobika, the device creates a series of rapid pressure pulses (oscillations). These pulses serve two main functions:
- Airway Splinting: The positive pressure holds the airways open, preventing them from collapsing during exhalation.
- Mucus Mobilization: The vibrations “shake” the mucus, thinning its consistency and shearing it away from the airway walls.
For children with CF, whose mucus is naturally thicker and stickier, this dual-action mechanism is a vital alternative to or enhancement of traditional chest physiotherapy (CPT).
Is the Aerobika Safe for Kids? Core Safety Features
The short answer is yes, the Aerobika is widely considered safe for children who are old enough to follow the breathing instructions (typically ages 4 and up). Its safety profile is rooted in its material composition and mechanical design.
Medical-Grade, Non-Toxic Construction
In the context of long-term pediatric care, the materials that come into contact with your child’s mouth and airways are critical. The Aerobika is manufactured with the following safety standards:
- BPA-Free: Contains no Bisphenol A, an industrial chemical often found in plastics that can interfere with hormonal systems.
- Latex-Free: Safe for children with natural rubber latex allergies, preventing potential anaphylactic or dermatological reactions.
- Phthalate-Free & Lead-Free: The device avoids common plasticizers and heavy metals often found in lower-grade plastics.
Safety for Daily Use and Sterilization
Because CF patients are at a higher risk for pulmonary infections, the ability to disinfect a device is a safety requirement. The Aerobika is designed to withstand high-heat sterilization, including:
- Boiling: Can be safely boiled for 5 minutes.
- Dishwasher: Top-rack safe (in a basket).
- Microwave Steam Bags: Compatible with standard medical steam cleaning bags.
Benefits of Using the Aerobika in Pediatric CF Management
Using an OPEP device like the Aerobika offers several clinical and lifestyle advantages for Australian families managing cystic fibrosis.
1. Improved Mucus Clearance
Clinical studies have shown that OPEP therapy can be as effective as traditional chest percussion but often takes less time. This efficiency is crucial for maintaining compliance in school-aged children.
2. Simultaneous Nebuliser Therapy
One of the unique safety and efficiency features of the Aerobika is its compatibility with small-volume nebulisers. This allows children to receive their inhaled medications (like hypertonic saline) while simultaneously performing their airway clearance, reducing the total “treatment burden” time.
3. Five Adjustable Resistance Settings
Every child’s lung capacity is different. The Aerobika features an adjustable resistance dial. This allows a pediatric physiotherapist to “dial in” the exact pressure needed for the child’s current lung function, ensuring the treatment is neither too difficult nor ineffective.
How to Use the Aerobika with Children: A Step-by-Step Guide
Proper technique is essential to ensure the device is used safely and effectively. Always consult with your CF care team before starting.
- Set the Resistance: Ensure the indicator is on the setting prescribed by your physiotherapist (start low and move toward “+” as tolerated).
- Posture: Have your child sit upright with their elbows on a table to keep the chest open.
- The Seal: Place the mouthpiece in the mouth and ensure a tight seal with the lips.
- Inhalation: Instruct the child to take a breath slightly deeper than normal through their nose or the device.
- The Breath Hold: Hold the breath for 2–3 seconds to allow air to get behind the mucus.
- Active Exhalation: Have them blow out through the device for 3–4 seconds. The exhalation should be active but not forceful—like blowing up a balloon.
- Keep Cheeks Flat: Ensure the child keeps their cheeks firm; the vibrations should be felt in the chest, not the mouth.
- The Huff: After 10–20 breaths, perform 2–3 “huff coughs” to move the loosened mucus out.
Best Practices for Parents in Australia
Managing CF in the Australian climate and healthcare system involves a few specific best practices:
- Regular Replacement: In Australia, it is recommended to replace the Aerobika every 12 months to ensure the internal valve mechanism maintains its therapeutic frequency.
- Physiotherapy Review: Ensure your child’s technique is reviewed during their quarterly clinic visits at major centers like Westmead, Monash Children’s, or Queensland Children’s Hospital.
- Infection Control: Never share the device between siblings, even if both have CF, as this can lead to cross-contamination of bacteria like Pseudomonas aeruginosa.
Common Mistakes to Avoid
- Forceful Blowing: Exhaling too hard can cause airways to collapse prematurely. The goal is a steady, active “whirring” sound from the device.
- Puffed Cheeks: If the cheeks are vibrating, the energy of the oscillation is being lost in the mouth rather than the lungs.
- Inconsistent Cleaning: Skipping daily cleaning allows a biofilm to form inside the device, which could lead to respiratory infections.
FAQ: Frequently Asked Questions
At what age can a child start using the Aerobika?
Most clinicians suggest children can begin using the Aerobika around age 4, or once they are able to follow instructions for a “huff cough” and sustained exhalation.
Can the Aerobika replace manual chest physiotherapy?
For many, it is an adjunct or a primary method. However, any change to a child’s airway clearance routine must be approved by a specialized CF physiotherapist.
Is the Aerobika covered by the NDIS or Medicare?
In Australia, the Aerobika may be funded through NDIS plans under “Assistive Technology” or “Consumables,” depending on the child’s specific goals and funding categories.
How often should my child use it?
Standard therapy is usually 10–20 minutes twice daily, though this frequency often increases to 3–4 times daily during a pulmonary exacerbation.
Is it okay if my child coughs during the session?
Yes, coughing is the goal. However, try to encourage them to “suppress” the cough for 10 breaths to allow the vibrations to work deeper in the lungs before the final “huff.”
Conclusion
The Aerobika OPEP device is a safe, effective, and high-quality tool for pediatric cystic fibrosis management. Its BPA-free and latex-free construction provides parents with peace of mind regarding chemical exposure, while its clinically-backed oscillation technology offers a powerful way to keep young lungs clear. By integrating the Aerobika into a daily routine—and ensuring proper cleaning and technique—families can significantly improve their child’s respiratory health and quality of life.
Internal Linking Suggestions:
- Anchor text: “airway clearance techniques for CF”
- Anchor text: “managing pediatric respiratory health”
- Anchor text: “BPA-free medical devices for kids”
Authoritative External References:
- Cystic Fibrosis Australia – Clinical Guidelines for Physiotherapy
- Trudell Medical International – Aerobika Clinical Study Summary